Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: greens12, BrazenBull
Search This Board: 
Last Post: 6/27/2017 2:32:38 AM - Followers: 24 - Board type: Free - Posts Today: 2




Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.



We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Small Company Offering and Sale of Securities Without Registration (d) 06/22/2017 04:38:53 PM
VKTX News: Current Report Filing (8-k) 06/19/2017 04:33:42 PM
VKTX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 06/15/2017 05:15:32 PM
VKTX News: Current Report Filing (8-k) 06/14/2017 10:02:28 AM
VKTX News: Viking Therapeutics Announces $4.3 Million Registered Direct Offering 06/14/2017 09:55:00 AM
#400   The volume is good but for .5 Million greens12 06/27/17 02:32:38 AM
#399   always happy to see some volume BrazenBull 06/27/17 01:41:20 AM
#398   Thanks Waffles,I really appreciate your insight here. made greens12 06/24/17 01:09:19 PM
#397   It's all good buddy, we've all been at ZeWaffleBaron 06/24/17 12:54:44 PM
#396   So much riding on this I let my greens12 06/23/17 11:13:53 PM
#395   all good brother, was a tough week. I BrazenBull 06/23/17 11:06:14 PM
#394   wanted to say sorry to all on this greens12 06/23/17 10:53:11 PM
#393   Zacks research 7.00 valuation greens12 06/22/17 02:19:05 PM
#392   bouncing off 1.00 support greens12 06/22/17 02:04:28 PM
#391   Greens lol! alx8967 06/21/17 07:13:26 PM
#390   The first person to be fired from VKTX greens12 06/20/17 11:58:13 PM
#389   so glad I did not buy any warrants...this greens12 06/20/17 11:36:59 PM
#388   Good for you you feel like its Christmas greens12 06/20/17 10:40:05 PM
#387   Totally understand your position and frustrations. If ZeWaffleBaron 06/20/17 08:20:11 PM
#386   when will you be convinced that news was greens12 06/20/17 08:01:58 PM
#385   Management is as bad as it gets,...they all greens12 06/20/17 07:46:08 PM
#384   Scary. Hold on tight boys. We could see alx8967 06/20/17 05:51:51 PM
#383   What the hell happened. BrazenBull 06/20/17 03:49:50 PM
#382   We cancelled the 2016 deal with Aspire, this BrazenBull 06/19/17 07:23:24 PM
#381   Thanks for the reply, yeah my concern was greens12 06/17/17 07:18:53 PM
#380   They don't say if the dosing is monitored/observed ZeWaffleBaron 06/17/17 06:47:39 PM
#379   Study says dosed once daily. It takes ZeWaffleBaron 06/17/17 06:40:51 PM
#378   Yes sir good play alx8967 06/17/17 02:28:21 PM
#377   My goal is to make money, but I greens12 06/17/17 01:54:48 AM
#376   I don't think it will be that long greens12 06/16/17 11:58:43 AM
#375   Just sold off my regular brokerage account holdings alx8967 06/16/17 09:55:43 AM
#374   Viking is having trouble recruiting so yea it's alx8967 06/16/17 09:38:33 AM
#373   hey Waffles, i noticed many of the 33 greens12 06/16/17 01:10:14 AM
#372   Hi Waffles , The timing was terrible greens12 06/16/17 12:04:52 AM
#371   Thanks for the input! alx8967 06/15/17 04:13:54 PM
#370   Thank you sir! alx8967 06/15/17 04:13:40 PM
#369   looking to add more myself. I was not BrazenBull 06/15/17 12:20:50 AM
#368   Evening all. Wanted to give my thoughts ZeWaffleBaron 06/14/17 10:53:28 PM
#367   We need a new CEO, Brian needs to greens12 06/14/17 06:17:26 PM
#366   Slaughter of the stock today. Only the strong alx8967 06/14/17 04:15:28 PM
#365   Obviously I can attest to the improvement of alx8967 06/14/17 02:17:15 PM
#364   Hmm yes definitely benefits them more than us. alx8967 06/14/17 02:15:46 PM
#363   VKTX Management is terrible, they either do not greens12 06/14/17 02:00:44 PM
#362   1.15 Cbdpotential 06/14/17 01:13:29 PM
#361   Direct offering alert alx8967 06/14/17 10:19:54 AM
#360   Yes sir. It's encouraging that GTXI trades in alx8967 06/12/17 11:16:58 AM
#359   Thanks for the info, looks like VKTX is greens12 06/12/17 11:13:35 AM
#358   Check out my post on VKTX board regarding alx8967 06/12/17 10:54:53 AM
#357   Hey encouraging results from another sarm with GTXI alx8967 06/12/17 10:54:07 AM
#356   Looks like GTXI had some positive results from alx8967 06/12/17 10:50:44 AM
#355   "For valuation purposes, we have constructed a probability greens12 06/07/17 12:19:01 PM
#354   It hit 1.52 ++ in pre market today greens12 06/07/17 02:01:54 AM
#353   Retail will be chasing it soon, while Ligand greens12 06/06/17 09:24:01 PM
#352   "We are excited about the initial results from greens12 06/06/17 09:18:00 PM
#351   Lol! alx8967 06/06/17 02:31:41 PM